stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Shares outstanding
Alcon's shares outstanding at the end of fiscal 2025 was $496.2M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $488.7M. Over the past ten years it has ranged from $0.00 (fiscal 2016) to $497.5M (fiscal 2024); the current reading is higher than 80% of that period. Alcon ranks 4th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $496.2M | (0.26%) |
| FY2024 | $497.5M | 0.20% |
| FY2023 | $496.5M | 0.42% |
| FY2022 | $494.4M | 0.20% |
| FY2021 | $493.4M | 0.90% |
| FY2020 | $489.0M | 0.16% |
| FY2019 | $488.2M | 0.00% |
| FY2018 | $488.2M | (0.16%) |
| FY2017 | $489.0M | — |
| FY2016 | $0.00 | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $488.7M | (0.31%) |
| Mar 2026 | $490.2M | (1.21%) |
| Dec 2025 | $496.2M | 0.06% |
| Sep 2025 | $495.9M | (0.40%) |
| 28 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $1.3B |
| BAX Baxter International Inc. compare | $520.0M |
| ALC Alcon | $488.7M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| RMD ResMed Inc. compare | $143.4M |
| ALGN Align Technology, Inc. compare | $71.0M |
| WST West Pharmaceutical Services, Inc. compare | $70.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement